Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Scatchard, Kate M"'
Autor:
Clamp AR; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK., James EC; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: E.james@ucl.ac.uk., McNeish IA; Department of Surgery and Cancer, Imperial College London, London, UK., Dean A; Oncology, St John of God Hospital, Subiaco, WA, Australia., Kim JW; Department of Obstetrics and Gynecology, Seoul National University, Seoul, South Korea., O'Donnell DM; Cancer Trials Ireland, Dublin, Ireland., Gallardo-Rincon D; Department of Medical Oncology, Instituto Nacional de Cancerologia, Mexico City, Mexico., Blagden S; Department of Oncology, Churchill Hospital, University of Oxford, Oxford, UK., Brenton J; Li Ka Shing Centre, Cancer Research UK Cambridge Institute, Cambridge, UK., Perren TJ; Leeds Institute of Medical Research, St James' University Hospital, Leeds, UK., Sundar S; Institute of Cancer and Genomics, University of Birmingham, Birmingham, UK., Lord R; Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK., Dark G; Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Hall M; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK., Banerjee S; Gynaecological Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK., Glasspool RM; Beatson West of Scotland Cancer Centre, Glasgow, UK., Hanna CL; Department of Oncology, Velindre Cancer Centre, Cardiff, UK., Williams S; Birmingham City Hospital, Birmingham, UK., Scatchard KM; North Devon District Hospital, Barnstaple, UK; Exeter Oncology Centre, Royal Devon and Exeter Hospital, Exeter, UK., Nam H; Broomfield Hospital, Chelmsford, UK; Southend University Hospital, Southend, UK., Essapen S; St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, UK., Parkinson C; Cambridge Cancer Centre, Addenbrooke's Hospital, Cambridge, UK., McAvan L; Department of Oncology, University Hospital Coventry and Warwickshire, Coventry, UK., Swart AM; Norwich Clinical Trials Unit, Norwich Medical School, University of East Anglia, Norwich, UK., Popoola B; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Schiavone F; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Badrock J; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Fananapazir F; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Parmar M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Kaplan R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Ledermann JA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute and UCL Hospitals, London, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Jul; Vol. 23 (7), pp. 919-930. Date of Electronic Publication: 2022 Jun 09.